Concepedia
Statistics
Publications
3
Citations
291
H-Index
Active since
2009
Affiliations
Cancer Research UK(Current)
Institute of Cancer Research
Queen's University Belfast
Anna Zetterlund is an author at Cancer Research UK specializing in oncology, medicine, and cancer pharmacology.
Publications per year
2009–2012
A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
Simon Pacey, Richard H. Wilson, Mike Walton et al. · Clinical Cancer Research · 2011 · 190 citations · Full text
Medicine, Oncology, Pharmacology +17
AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
Timothy A. Yap, Mike I. Walton, Kyla M. Grimshaw et al. · Clinical Cancer Research · 2012 · 91 citations · Full text
A phase I trial of the HSP90 inhibitor, alvespimycin (17-DMAG) administered weekly, intravenously, to patients with advanced, solid tumours
Simon Pacey, Richard H. Wilson, Michael Walton et al. · Journal of Clinical Oncology · 2009 · 10 citations
1–3 of 3